Detalles de la búsqueda
1.
Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
Br J Haematol
; 204(4): 1279-1287, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38131400
2.
Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 103(5): 1737-1744, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38509389
3.
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis.
Cancer Sci
; 114(9): 3719-3727, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365854
4.
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
Br J Haematol
; 202(2): 256-266, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096915
5.
[Acute promyelocytic leukemia with asymptomatic cerebral hemorrhage].
Rinsho Ketsueki
; 64(11): 1426-1430, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-38072429
6.
[Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy].
Rinsho Ketsueki
; 64(5): 331-337, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-37271521
7.
[Perioperative management of laparoscopic cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab treatment].
Rinsho Ketsueki
; 63(4): 260-264, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35491214
8.
[Marginal zone lymphoma-like primary bone marrow lymphoma with long-term pancytopenia preceding diagnosis].
Rinsho Ketsueki
; 61(10): 1469-1475, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-33162442
9.
[Novel therapies for acute myeloid leukemia based on genomic aberrations].
Rinsho Ketsueki
; 60(6): 594-599, 2019.
Artículo
en Japonés
| MEDLINE | ID: mdl-31281150
10.
Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1).
J Biol Chem
; 292(48): 19639-19655, 2017 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28974577
11.
[False positive (18)F-FDG PET/CT uptake by fat necrosis during chemotherapy for malignant lymphoma].
Rinsho Ketsueki
; 54(1): 127-9, 2013 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-23391657
12.
Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia.
Int J Hematol
; 117(1): 24-29, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36087226
13.
Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors.
Int J Hematol
; 118(4): 519-525, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37131080
14.
Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma.
Clin Case Rep
; 10(2): e05372, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35154721
15.
A Rare Case of Radiation-Induced Liver Disease in Treated Abdominal Lymphoma Showing High [18F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose.
Diagnostics (Basel)
; 12(2)2022 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35204594
16.
A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cellsurface proteins on target cells.
Int J Mol Med
; 49(4)2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35119085
17.
Severe Motor Weakness Due to Disturbance in Peripheral Nerves Following Tisagenlecleucel Treatment.
In Vivo
; 35(6): 3407-3411, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34697176
18.
Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells.
Cancers (Basel)
; 12(2)2020 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32050632
19.
Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.
Cancer Lett
; 453: 84-94, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30946869
20.
Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy.
Anticancer Res
; 39(9): 5115-5122, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31519623